Review of TB treatment outcomes stratified by baseline CD4+ T-cell count distribution reveals that those patients with a CD4 count of <50 cells/mm3 had the highest proportion of death (10.7%) and accounted for over half of the deaths in the entire cohort (Table 3(a)). This evidence concerns the gene CD4 and tuberculosis.